Worth reading
49Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
637200
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights for compensation purposes (stock compensation stock options)
発行・処分する株式数
Up to 637,200 shares (6,372 stock acquisition rights × 100 shares per right)
Intended allottee
Category The Company's executive officers / Number of Employees 13 / Number of stock acquisition rights 3,972, Category Presidents and other officers of the Company's Group companies / Number of Employees 37 / Number of stock acquisition rights 2,400
The accounting fair value as of the allotment date for each stock acquisition right
Terms of the stock acquisition rights
Exercise price
¥1 per share. No adjustment provisions are specified.
Exercise period
Start Date 21 July 2027 / End date 20 July 2042
Number of Stock Acquisition Rights
Total number issued Up to 6,372 / Number of unexercised units Not disclosed
Reason for acquisition without consideration
Expiration of the exercise period, the passage of 5 years from the retirement date, a serious violation of laws or internal rules, a criminal sentence involving imprisonment or a more severe penalty, appointment to a competing company without authorization, dismissal, removal from office or demotion, the death of a successor to the rights, an application to waive all rights, or a resolution by the Board of Directors to acquire all or part of the rights.
Conditions on transfer restrictions
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
Conditions for lifting transfer restrictions
If the holder retires as an executive officer or otherwise ceases to hold the relevant position, the rights may be exercised only within 5 years from the retirement date. The holder must also remain an executive officer or otherwise hold the relevant position at the time of exercise.
Categories and Number of Persons Covered
Category The Company's executive officers / Number of Employees 13 / Number of allocated stock acquisition rights 3,972, Category Presidents and other officers of the Company's Group companies / Number of Employees 37 / Number of allocated stock acquisition rights 2,400
Intended allottee's holding policy
The holders of the stock acquisition rights and their successors may not transfer the stock acquisition rights or pledge them as collateral.
Basis for determining the amount to be paid
Fair value for accounting purposes as of the allotment date
Procedures under the Corporate Code of Conduct
Decided at meetings of the Compensation Committee and the Board of Directors held on 27 May 2026. Allotments to the Company's executive officers will be decided by the Compensation Committee, while allotments to presidents and other officers of the Company's Group companies will be decided by the Board of Directors based on a proposal from the Compensation Committee.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights for compensation purposes (stock compensation stock options) |
| Number of shares to be issued or disposed of | Up to 637,200 shares (6,372 stock acquisition rights × 100 shares per right) |
| Issue price and disposal price | The accounting fair value as of the allotment date for each stock acquisition right |
| Intended allottee | Category The Company's executive officers / Number of Employees 13 / Number of stock acquisition rights 3,972, Category Presidents and other officers of the Company's Group companies / Number of Employees 37 / Number of stock acquisition rights 2,400 |
| Intended allottee's holding policy | The holders of the stock acquisition rights and their successors may not transfer the stock acquisition rights or pledge them as collateral. |
| Basis for determining the amount to be paid | Fair value for accounting purposes as of the allotment date |
| Exercise price | ¥1 per share. No adjustment provisions are specified. |
| Exercise period | Start Date 21 July 2027 / End date 20 July 2042 |
| Number of Stock Acquisition Rights | Total number issued Up to 6,372 / Number of unexercised units Not disclosed |
| Conditions for lifting transfer restrictions | If the holder retires as an executive officer or otherwise ceases to hold the relevant position, the rights may be exercised only within 5 years from the retirement date. The holder must also remain an executive officer or otherwise hold the relevant position at the time of exercise. |
| Reason for acquisition without consideration | Expiration of the exercise period, the passage of 5 years from the retirement date, a serious violation of laws or internal rules, a criminal sentence involving imprisonment or a more severe penalty, appointment to a competing company without authorization, dismissal, removal from office or demotion, the death of a successor to the rights, an application to waive all rights, or a resolution by the Board of Directors to acquire all or part of the rights. |
| Categories and Number of Persons Covered | Category The Company's executive officers / Number of Employees 13 / Number of allocated stock acquisition rights 3,972, Category Presidents and other officers of the Company's Group companies / Number of Employees 37 / Number of allocated stock acquisition rights 2,400 |
| Procedures under the Corporate Code of Conduct | Decided at meetings of the Compensation Committee and the Board of Directors held on 27 May 2026. Allotments to the Company's executive officers will be decided by the Compensation Committee, while allotments to presidents and other officers of the Company's Group companies will be decided by the Board of Directors based on a proposal from the Compensation Committee. |
Items this document does not state (15)
Total issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateDilution RateTotal number of issued sharesTransfer restriction periodTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To enhance the motivation and morale of executive officers and others to achieve sustained improvement in business performance and increase corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.